<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2637985</article-id><article-id pub-id-type="pmid">19221602</article-id><article-id pub-id-type="publisher-id">08-PONE-RA-06540R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004481</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Nutrition</subject><subject>Genetics and Genomics/Functional Genomics</subject><subject>Genetics and Genomics/Gene Expression</subject><subject>Genetics and Genomics/Gene Function</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Age and Diet Affect Gene Expression Profile in Canine Skeletal Muscle </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Canine Muscle Gene Expression</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Middelbos</surname><given-names>Ingmar S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vester</surname><given-names>Brittany M.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Karr-Lilienthal</surname><given-names>Lisa K.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schook</surname><given-names>Lawrence B.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Swanson</surname><given-names>Kelly S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Animal Sciences, University of Illinois, Urbana, Illinois, United States of America</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Division of Nutritional Sciences, University of Illinois, Urbana, Illinois, United States of America</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Veterinary Clinical Medicine, University of Illinois, Urbana, Illinois, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Bridger</surname><given-names>Joanna Mary</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Brunel University, United Kingdom</aff><author-notes><corresp id="cor1">* E-mail: <email>ksswanso@illinois.edu</email></corresp><fn fn-type="con"><p><text><SENT sid="1" pm="."><plain>Conceived and designed the experiments: LBS KSS. </plain></SENT>
<SENT sid="2" pm="."><plain>Performed the experiments: BMV LKKL KSS. </plain></SENT>
<SENT sid="3" pm="."><plain>Analyzed the data: ISM BMV LKKL KSS. </plain></SENT>
<SENT sid="4" pm="."><plain>Wrote the paper: ISM KSS. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>16</day><month>2</month><year>2009</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e4481</elocation-id><history><date date-type="received"><day>23</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Middelbos et al.</copyright-statement><copyright-year>2009</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="5" pm="."><plain>We evaluated gene transcription in canine skeletal muscle (biceps femoris) using microarray analysis to identify effects of age and diet on gene expression. </plain></SENT>
<SENT sid="6" pm="."><plain>Twelve female beagles were used (six 1-year olds and six 12-year olds) and they were fed one of two experimental diets for 12 months. </plain></SENT>
<SENT sid="7" pm="."><plain>One diet contained primarily plant-based protein sources (PPB), whereas the second diet contained primarily animal-based protein sources (APB). </plain></SENT>
<SENT sid="8" pm="."><plain>Affymetrix GeneChip Canine Genome Arrays were used to hybridize extracted RNA. </plain></SENT>
<SENT sid="9" pm="."><plain>Age had the greatest effect on gene transcription (262 differentially expressed genes), whereas the effect of diet was relatively small (22 differentially expressed genes). </plain></SENT>
<SENT sid="10" pm="."><plain>Effects of age (regardless of diet) were most notable on genes related to metabolism, cell cycle and cell development, and transcription function. </plain></SENT>
<SENT sid="11" pm="."><plain>All these genes were predominantly down-regulated in geriatric dogs. </plain></SENT>
<SENT sid="12" pm="."><plain>Age-affected genes that were differentially expressed on only one of two diets were primarily noted in the PPB diet group (144/165 genes). </plain></SENT>
<SENT sid="13" pm="."><plain>Again, genes related to cell cycle (22/35) and metabolism (15/19) had predominantly decreased transcription in geriatric dogs, but 6/8 genes related to muscle development had increased expression. </plain></SENT>
<SENT sid="14" pm="."><plain>Effects of diet on muscle gene expression were mostly noted in geriatric dogs, but no consistent patterns in transcription were observed. </plain></SENT>
<SENT sid="15" pm="."><plain>The insight these data provide into gene expression profiles of canine skeletal muscle as affected by age, could serve as a foundation for future research pertaining to age-related muscle diseases. </plain></SENT>
</text></SecTag></p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="16" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="17" pm="."><plain>Aging mammals display a decline in a multitude of physical and physiological functions. </plain></SENT>
<SENT sid="18" pm="."><plain>In addition to impaired cognitive function [1], [2] with age, muscle function and strength may also decline [3]. </plain></SENT>
<SENT sid="19" pm="."><plain>The decline in muscle function in aging dogs is attributed to oxidative damage to lipids, proteins, and DNA that accumulates over time [4]. </plain></SENT>
<SENT sid="20" pm="."><plain>In metabolically active muscle tissue, mitochondrial DNA damage leads to dysfunction [5] and may lower oxygen uptake capacity thus decreasing muscle function [6]. </plain></SENT>
<SENT sid="21" pm="."><plain>Decreased expression of genes related to the electron transport chain, energy metabolism, and mitochondrial protein synthesis have been reported in aged human skeletal muscle [7], [8]. </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>Typical dietary effects on gene expression are noted with caloric restriction, which not only slows the aging process, but also mediates the transcription of metabolic and biosynthetic genes [9]. </plain></SENT>
<SENT sid="23" pm="."><plain>Additionally, in a calorically restricted state, mitochondria have been reported to decrease oxygen consumption, generate fewer reactive oxygen species, and maintain critical ATP production [10]. </plain></SENT>
<SENT sid="24" pm="."><plain>Other dietary manipulations, including differences in protein source, have also been shown to affect hepatic and skeletal muscle gene expression in rats [11]. </plain></SENT>
</text></p><p><text><SENT sid="25" pm="."><plain>Muscle gene expression in dogs has been evaluated for some select genes under pathogenic [12] and varying dietary conditions [13] but no large-scale profiling data are available. </plain></SENT>
<SENT sid="26" pm="."><plain>Therefore, the aim of this study was to investigate the effects of age and dietary composition on gene expression in skeletal muscle of dogs. </plain></SENT>
<SENT sid="27" pm="."><plain>This experiment was part of a larger study investigating the effects of age and dietary composition on various physiologic and genomic outcomes. </plain></SENT>
<SENT sid="28" pm="."><plain>We previously demonstrated that diet and age affected whole body metabolism [14], intestinal morphology and fermentative end-products [15], and cerebral cortex gene expression [16]. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec id="s2"><title><text><SENT sid="29" pm="."><plain>Results and Discussion </plain></SENT>
</text></title><p><text><SENT sid="30" pm="."><plain>Diets fed in this study were previously reported to affect nutrient digestibility [14], gut morphology [15], and gene transcription of cerebral cortex tissue [16]. </plain></SENT>
<SENT sid="31" pm="."><plain>Age was reported to have the greatest effect on cerebral cortex gene expression, whereas the effects of diet were relatively small. </plain></SENT>
<SENT sid="32" pm="."><plain>Geriatric dogs had increased expression of genes related to inflammation and stress response, as well as calcium homeostasis, whereas gene expression related to neurotransmission was decreased [16]. </plain></SENT>
</text></p><p><text><SENT sid="33" pm="."><plain>In canine skeletal muscle, age had the strongest effect on mRNA abundance, whereas the effect of diet was less pronounced. </plain></SENT>
<SENT sid="34" pm="."><plain>A total of 390 probe sets were significantly changed with age in either pairwise comparison (old vs. young fed APB; old vs. young fed PPB), whereas only 30 probe sets were significantly changed due to diet in either pairwise comparison (APB vs. PPB in old dogs; APB vs. PPB in young dogs). </plain></SENT>
<SENT sid="35" pm="."><plain>After eliminating probe sets that represented unannotated genes and correcting for multiple probe sets that represented the same gene, 262 genes were differentially expressed due to age, whereas 22 genes were differentially expressed due to diet. </plain></SENT>
<SENT sid="36" pm="."><plain>All microarray data have been deposited in the Gene Expression Omnibus repository at the National Center for Biotechnology Information archives (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">http://www.ncbi.nlm.nih.gov/geo</ext-link>) under accession #GSE12502. </plain></SENT>
</text></p><p><text><SENT sid="37" pm="."><plain>The heat map in Figure 1 clearly demonstrates the strong and consistent effect of age, but also highlights some inconsistencies, particularly in geriatric dogs fed the APB diet. </plain></SENT>
<SENT sid="38" pm="."><plain>Although age was the primary factor by which dogs were clustered, dogs also clustered according to diet within age groups. </plain></SENT>
<SENT sid="39" pm="."><plain>Of the 262 genes that were affected by age, only 26 were differentially expressed in both diet groups (Tables 1, 2, and 3). </plain></SENT>
<SENT sid="40" pm="."><plain>Of the total 22 differentially expressed genes due to diet, none were differentially expressed in both age groups (Table 4). </plain></SENT>
<SENT sid="41" pm="."><plain>Analysis of several genes using qRT-PCR confirmed our observations on the array, with MT2A, TTN, and ATP2B all having increased mRNA abundance according to both the array and qRT-PCR (data not shown). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0004481-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="42" pm="."><plain>Heat map of pairwise comparisons of skeletal muscle gene expression in geriatric versus young adult dogs. </plain></SENT>
</text></title><p><text><SENT sid="43" pm="."><plain>Values are the GCRMA-processed probe set value (log2 scale) minus the mean value for that probe set across all arrays. </plain></SENT>
<SENT sid="44" pm="."><plain>Hierarchical cluster analysis was used to create the dendrogram. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0004481.g001"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="pone-0004481-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="45" pm="."><plain>Differentially expressed cell function- and immune response-associated genes in skeletal muscle tissue of geriatric vs. young adult dogs fed diets formulated with animal-based (APB) or plant-based (PPB) protein sources. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0004481-t001-1" xlink:href="pone.0004481.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="46" pm="."><plain>Functional classification </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="47" pm="."><plain>Gene name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>Gene symbol </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="49" pm="."><plain>Fold change </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>APB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>PPB </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="52" pm="."><plain>Cell cycle and apoptosis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>Apoptosis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>TIMP metallopeptidase inhibitor 3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>TIMP3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>1.36 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>1.90* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>Apoptosis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>Diablo homolog (drosophila) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>DIABLO </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>−1.25 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>−2.18* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>Cell adhesion </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>Endoglin (osler-rendu-weber syndrome 1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>ENG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>−2.85* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>−3.61* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>Cell aging </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>LIM and senescent cell antigen-like domains 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>LIMS1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>1.31 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>3.13* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>Cell cycle </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Stromal interaction molecule 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>STIM1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>−1.60* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>−1.95* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>Cell cycle </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>Transforming growth factor, beta 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>TGFB1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>−1.54 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>−2.12* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Cell cycle (inhibition) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>Retinoblastoma-like 2 (p130) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>RBL2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>1.61 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>3.45* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>Cell proliferation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>RAS homolog gene family, member g (rho g) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>RHOG </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>−1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>−1.65* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>Cell survival </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>Hcls1 associated protein x-1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>HAX1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>−1.56* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>−1.80* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>Differentiation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>Endothelial pas domain protein 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>EPAS1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>−1.69* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>−2.10* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>Meiotic recombination </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>Kelch domain containing 3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>KLHDC3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>−1.57* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>−1.77* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>Proliferation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>Calpain, small subunit 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>CAPNS1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>−1.36* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>−1.41* </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="113" pm="."><plain>Cellular organization and development </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>Actin cytoskeleton organization and development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>Phosphodiesterase 4 d interacting protein (myomegalin) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>PDE4DIP </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>1.30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>1.90* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>Cytokinesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>Myosin-10 (cellular myosin heavy chain, type b) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>MYH10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>3.19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>6.22* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>Cytokinesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>Septin 11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>SEPT11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>2.52* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>3.79* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>Cytoskeletal organization </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>Actin binding lim protein 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>ABLIM1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>2.23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>3.17* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>MYBPC1 myosin binding protein C, slow type </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>MYBPC1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>1.82 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>4.14* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>Nebulin </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>NEB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>1.86 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>3.16* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Titin </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>TTN </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>1.96 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>8.95* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>Myocyte enhancer factor 2C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>MEF2C </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>1.38 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>4.90* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>Integrin beta 1 binding protein (melusin) 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>ITGB1BP2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>−2.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>−2.28* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>Development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>Actin, gamma 2, smooth muscle, enteric </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>ACTG2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>−2.72 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>−6.73* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>Structure </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>DMN desmuslin </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>DMN </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>2.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>8.41* </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="169" pm="."><plain>Immune and stress response </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>Anti tumor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>Dermatan sulfate epimerase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>DSE </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>4.81* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>4.49* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>Humoral immune response </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>Adenosine deaminase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>ADA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>−2.21* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>−2.58* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>Immune response </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>Gamma-interferon inducible lysosomal thiol reductase precursor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>IFI30/GILT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>−4.70* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>−5.30* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>Oxidative stress response </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>Peroxiredoxin 5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>PRDX5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>−1.90* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>−1.90* </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>*</label><p><text><SENT sid="190" pm="."><plain>Denotes statistically significant differences. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0004481-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="191" pm="."><plain>Differentially expressed metabolism-associated genes in skeletal muscle tissue of geriatric vs. young adult dogs fed diets formulated with animal-based (APB) or plant-based (PPB) protein sources. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0004481-t002-2" xlink:href="pone.0004481.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>Functional classification </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>Gene name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>Gene symbol </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="195" pm="."><plain>Fold change </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>APB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>PPB </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="198" pm="."><plain>Metabolism </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>Amino acid metabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>Cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>CCBL1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>−2.48* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>−2.08* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>Carbohydrate metabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>ER degradation enhancer, mannosidase alpha-like 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>EDEM2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>−1.36* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>−1.66* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>Electron transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22 kDa </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>DNDUFB9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>−1.29 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>−1.37* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>Electron transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>Isovaleryl Coenzyme A dehydrogenase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>IVD </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>−1.50 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>−1.69* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>Electron transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13 kDa (NADH-coenzyme Q reductase) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>NDUFS6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>−1.22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>−1.42* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>Electron transport chain </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>NADH dehydrogenase 1 beta subcomplex, 11, 17.3 kda </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>NDUFB11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>−1.61* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>−1.71* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>Electron transport chain </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>Ring finger 144b </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>RNF144B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>−2.79* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>−2.56* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>Electron transport chain </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>Glutaryl-Coenzyme A dehydrogenase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>GCDH </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>−2.01* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>−1.50 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>Energy metabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42 kDa </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>NDUFA10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>−1.66* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>−1.46 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>Lipid metabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>Protein kinase, AMP-activated, gamma 1 non-catalytic subunit </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>PRKAG1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>−1.41 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>−2.10* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>Glutathione conjugation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>Glutathione S-transferase P (GST 7-7) (Chain 7) (GST class-pi) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>GSTP1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>−1.22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>−1.77* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>Glycolysis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>Glyceraldehyde-3-phosphate dehydrogenase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>GAPDH </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>−1.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>−2.13* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>Glycolysis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>Aldolase A, fructose-bisphosphate </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>ALDOA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>1.53 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>2.54* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>Heme biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>Heme a∶farnesyltransferase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>COX10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>−1.57* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>−1.54* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>Lipid metabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>Hydroxysteroid (17-beta) dehydrogenase 10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>HSD17B10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>−1.76* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>−1.83* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>Protein AA dephosphorylation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>Protein phosphatase 2, regulatory subunit B″, alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>PPP2R3A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>1.30 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>3.67* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>Protein AA phosphorylation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>Janus kinase 1 (a protein tyrosine kinase) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>JAK1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>1.66 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>3.64* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>TCA cycle </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>Isocitrate dehydrogenase 3 (NAD+) beta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>IDH3B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>−2.19* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>−2.23* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>TCA cycle </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>Succinate dehydrogenase complex, subunit C, integral membrane protein, 15 kDa </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>SDHC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>−1.43* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>−1.34 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label>*</label><p><text><SENT sid="294" pm="."><plain>Denotes statistically significant differences. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0004481-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="295" pm="."><plain>Differential expression of transcription-, signaling-, and transport-associated genes in skeletal muscle tissue of geriatric vs. young adult dogs fed diets formulated with animal-based (APB) or plant-based (PPB) protein sources. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0004481-t003-3" xlink:href="pone.0004481.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>Functional classification </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>Gene name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>Gene symbol </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="299" pm="."><plain>Fold change </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>APB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>PPB </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="302" pm="."><plain>Transcription - translation </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>DNA structure </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>Polymerase (DNA-directed), epsilon 4 (p12 subunit) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>POLE4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>−1.20* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>−1.32* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>mRNA processing </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>Small nuclear ribonucleoprotein polypeptide N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>SNRPN </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>−1.54* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>−1.73* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>Deoxyhypusine synthase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>DHPS </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>−1.45 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>−2.03* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>Mitochondrial ribosomal protein L14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>MRPL14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>−1.37 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>−1.65* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>Mitochondrial ribosomal protein S18A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>MRPS18A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>−1.34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>−1.72* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>Ribosomal protein S16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>RPS16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>−1.15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>−2.00* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>Ribosomal protein L19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>RPL19 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>−1.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>−1.67* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>Protein biosynthesis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>Mitochondrial ribosomal protein S12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>MRPS12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>−1.42 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>−1.75* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>Ribosome assembly </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>Nucleolar protein family a, member 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>NOLA2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>−1.36* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>−1.89* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>Transcription regulation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>Zinc finger protein 32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>ZNF32 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>−1.63* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>−1.75* </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="353" pm="."><plain>Signaling mechanisms </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>Cellular trafficking </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>Methylmalonic aciduria cblc type, with homocystinuria </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>MMACHC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>−2.21* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>−2.15* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>Intracellular signaling cascade </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>A kinase (prka) anchor protein 13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>AKAP13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>1.96* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>1.86* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>Neurotransmission </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>Rab3a, member ras oncogene family </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>RAB3A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>−2.27* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>−2.22* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>Transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>Protein transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>Sec61 alpha 2 subunit (s. </plain></SENT>
<SENT sid="372" pm="."><plain>Cerevisiae) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>SEC61A2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>−1.54* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>−1.45* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>Taurine transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>Solute carrier family 6 (neurotransmitter transporter), member 6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>SLC6A6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>1.87* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>2.40* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>Transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>Solute carrier family 25, member 33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>SLC25A33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>−3.14* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>−3.42* </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label>*</label><p><text><SENT sid="386" pm="."><plain>Denotes statistically significant differences. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0004481-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="387" pm="."><plain>Effect of an animal protein-based vs. a plant protein-based diet on muscle gene expression in young adult or geriatric dogs. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0004481-t004-4" xlink:href="pone.0004481.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>Functional classification </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>Gene name </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>Gene symbol </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="391" pm="."><plain>Fold change </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>Young </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>Geriatric </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="394" pm="."><plain>Cellular organization and development </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Muscle function and development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>Titin </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>TTN </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>1.16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>−4.77* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>Striated muscle development </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>Myosin binding protein C, slow type </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>MYBPC1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>−1.02 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>−1.46* </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="405" pm="."><plain>Metabolism </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Diabetes and obesity </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Fat mass and obesity associated </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>FTO </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>−1.07 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>−1.39* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>Electron transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>Monoamine oxidase B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>MAOB </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>−2.61* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>1.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>Glycolysis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>Glyceraldehyde-3-phosphate dehydrogenase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>GAPDH </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>1.06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>2.01* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>Leucine catabolism </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>Methylcrotonyl-Coenzyme A carboxylase 2 (beta) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>MCCC2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>1.91* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>1.11 </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="426" pm="."><plain>Transcription - translation </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>Transcription regulation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>Zinc finger, MYND-type containing 8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>ZMYND8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>−1.07 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>−1.69* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>Transcription regulation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>SNF8, ESCRT-II complex subunit </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>SNF8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>−1.34* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>−1.02 </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="437" pm="."><plain>Signaling mechanisms </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>Cell surface receptor-linked Signal transduction </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>Leukemia inhibitory factor receptor alpha </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>LIFR </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>−2.20* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>Intracellular signaling cascade </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>Janus kinase 1 (a protein tyrosine kinase) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>JAK1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>−1.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>−2.17* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>Signal transduction </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>A kinase (PRKA) anchor protein 8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>AKAP8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>−1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>−1.35* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>Signal transduction </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>GNB2L1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>−1.05 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>−1.52* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>Signal transduction </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>Fasciculation and elongation protein zeta 2 (zygin II) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>FEZ2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>−1.52 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>−1.68* </plain></SENT>
</text></td></tr><tr><td colspan="5" align="left" rowspan="1"><text><SENT sid="463" pm="."><plain>Other </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>Apoptosis </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>Thioredoxin-like 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>TXNL1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>1.29* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>Calcium transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>ATPase, Ca++ transporting, plasma membrane 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>ATP2B1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>1.01 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>−1.55* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>Cell adhesion </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>Collagen, type I alpha 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>COL1A2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>−1.26 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>−2.68* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>Lipid transport </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>Glycolipid transfer protein domain containing 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>GLTP </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>−1.01 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>2.30* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>Mitotic chromosome condensation </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>Cytoplasmic linker associated protein 2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>CLASP2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>−1.14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>−2.23* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>Peptidase </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Signal peptide peptidase 3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>UNQ1887 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>−1.59* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>1.05 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>Protein complex assembly </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>Solute carrier family 9 (Na/H exchanger) member 3 regulator 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>SLC9A3R1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>−1.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>1.21* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>Unknown </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>Growth hormone regulated TBC protein 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>GRTP1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>1.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>1.37* </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>Visual perception </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>Crystallin, zeta </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>CRYZ </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>−1.06 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>−1.38* </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label>*</label><p><text><SENT sid="509" pm="."><plain>Denotes statistically significant differences. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="510" pm="."><plain>The expression of genes related to cell cycle and apoptosis in geriatric dogs versus young adults suggests decreased cell turnover and increased apoptotic cells in geriatric individuals. </plain></SENT>
<SENT sid="511" pm="."><plain>Genes that promote proliferation (e.g., CAPNS1) and differentiation (e.g., EPAS1) had decreased expression in geriatric dogs. </plain></SENT>
<SENT sid="512" pm="."><plain>On the other hand, genes related to induction of apoptosis, cell aging, and cell cycle inhibition (TIMP3, LIMS1, and RBL2) had increased expression in geriatric dogs. </plain></SENT>
<SENT sid="513" pm="."><plain>Nevertheless, DIABLO, whose down-regulation (in geriatric dogs fed PPB) suggests decreased apoptosis, contradicts the above described pattern of decreased cell turnover and increased apoptosis. </plain></SENT>
<SENT sid="514" pm="."><plain>This observation may be due to the method by which each gene induces cell death. </plain></SENT>
<SENT sid="515" pm="."><plain>TIMP3 stabilizes TNFα receptors on the cell surface, priming the cell for TNF-induced death often seen in cancerous cells [17], whereas DIABLO acts through inhibition of apoptosis inhibitor proteins [18]. </plain></SENT>
</text></p><p><text><SENT sid="516" pm="."><plain>Decreased expression of ENG and TGFB1 (in geriatric dogs fed PPB) suggests decreased cell turnover in geriatric dogs. </plain></SENT>
<SENT sid="517" pm="."><plain>ENG or endoglin is a co-receptor for TGFB1 that controls endothelial cell proliferation and angiogenesis [19]. </plain></SENT>
<SENT sid="518" pm="."><plain>ENG has been identified in muscle satellite cells or myogenic progenitors (MPs), but in contrast to our findings, Beggs et al. [20] noted increased expression of ENG in aged MPs compared to adult MPs (8-month old mice vs. 23-month old mice). </plain></SENT>
</text></p><p><text><SENT sid="519" pm="."><plain>Interestingly, STIM1, a gene related to cell growth suppression [21], was up-regulated in young adult dogs. </plain></SENT>
<SENT sid="520" pm="."><plain>STIM1 controls intracellular calcium homeostasis in conjunction with STIM2 [22], [23]. </plain></SENT>
<SENT sid="521" pm="."><plain>Calcium is an important second messenger, which may affect cell functions, including growth, and, specifically for muscle, contraction. </plain></SENT>
<SENT sid="522" pm="."><plain>Moreover, calcium is a co-factor for CAPNS1, which controls the stability of calpains (both µ and m) [24]. </plain></SENT>
<SENT sid="523" pm="."><plain>Therefore, by dependency, calcium (and possibly STIM) may control CAPNS1 and have strong control over cell proliferation and apoptosis. </plain></SENT>
<SENT sid="524" pm="."><plain>Additionally, the calpain system may play a role in stress or damage response [25]. </plain></SENT>
</text></p><p><text><SENT sid="525" pm="."><plain>In general, the up-regulation of genes related to cell cycle and proliferation in young adult dogs is not surprising as they have a higher rate of tissue turnover. </plain></SENT>
<SENT sid="526" pm="."><plain>For example, HAX1 (decreased in geriatric dogs) was increased in human psoriasis (epidermal hyperplasia) patients, indicating its effect on cell proliferation [26] and suppression of apoptosis [27]. </plain></SENT>
<SENT sid="527" pm="."><plain>Expression of EPAS1, a hypoxia-induced gene, was also decreased in geriatric dogs. </plain></SENT>
<SENT sid="528" pm="."><plain>A lack of EPAS1 can have severe metabolic consequences, including multiple organ pathogenesis, dysregulated TCA cycle and fatty acid oxidation, and impaired homeostasis of reactive oxygen species [28]. </plain></SENT>
<SENT sid="529" pm="."><plain>In the healthy individuals, EPAS1 stimulates angiogenesis [29]. </plain></SENT>
<SENT sid="530" pm="."><plain>KLHDC3 (Peas in mouse) bears similarity to RAG2 normally found in the testis where it is thought to play a role in meiotic recombination [30], but its function in skeletal muscle is unknown. </plain></SENT>
<SENT sid="531" pm="."><plain>Collectively, these data suggest that cell cycle, cell proliferation, and cell differentiation were decreased in geriatric dogs versus young adult dogs, whereas apoptosis and cell aging may be increased. </plain></SENT>
<SENT sid="532" pm="."><plain>The measurement of indicators for apoptosis or cell turnover were not performed herein to confirm the mRNA data, but would be justified in future experiments. </plain></SENT>
</text></p><p><text><SENT sid="533" pm="."><plain>Concurrent with genes related to cell cycle in geriatric dogs, genes related to DNA transcription (e.g., POLE4 and ZNF32) were also down-regulated. </plain></SENT>
<SENT sid="534" pm="."><plain>Although the function of POLE4 has not been completely elucidated, it is thought to play a role in DNA replication (particularly chromatin folding) [31] in the late S-phase of mitotic cells and is therefore associated with cell proliferation [32]. </plain></SENT>
<SENT sid="535" pm="."><plain>ZNF32 has been implicated in human colon and adrenocortex cancers where its up-regulation was noted in “signature” gene expression profiles for these malignancies [33], [34]. </plain></SENT>
<SENT sid="536" pm="."><plain>Implications for ZNF32 expression in skeletal muscle and its relation to age are currently unknown. </plain></SENT>
</text></p><p><text><SENT sid="537" pm="."><plain>SNRPN is involved in mRNA processing and its dysfunction (by faulty imprinting) in humans is related to Prader-Willi and Angelman syndromes [35], which typically impair intelligence, cognitive development, and display low muscle tone (hypotonia). </plain></SENT>
<SENT sid="538" pm="."><plain>SNRPN expression appears to be ubiquitous in mice, including skeletal muscle [36] but specific information in canine muscle is lacking. </plain></SENT>
<SENT sid="539" pm="."><plain>Likewise, NOLA2 has not been described in canine skeletal muscle but its involvement in rRNA processing and particularly its role in the telomerase complex have primed NOLA2 as an indicator gene in human lung cancer [37]. </plain></SENT>
</text></p><p><text><SENT sid="540" pm="."><plain>A number of genes related to protein biosynthesis were expressed at lower levels in aged dogs compared to young adult dogs, specifically in those fed PPB. </plain></SENT>
<SENT sid="541" pm="."><plain>Most of these genes encode ribosomal proteins or subunits thereof, but specific functions of these proteins remain to be elucidated. </plain></SENT>
<SENT sid="542" pm="."><plain>Although they are not functionally categorized as being involved in transcription and translation in Table 3, RBL2 (cell cycle; Table 1) and PPP2R3A (metabolism; Table 2) both play a role in transcription and repress the cell cycle. </plain></SENT>
</text></p><p><text><SENT sid="543" pm="."><plain>The down-regulation of genes related to metabolism in skeletal muscle of geriatric dogs was not surprising, as aged muscle becomes less efficient due to mitochondrial dysfunction [5], [6], [38]. </plain></SENT>
<SENT sid="544" pm="."><plain>These age-related changes affect respiratory chain function [39] and, consequently, reduce VO2max thereby diminishing muscle function [6] and muscle strength [3]. </plain></SENT>
<SENT sid="545" pm="."><plain>These age-related changes likely affect genes involved with the respiratory chain (NDUFB11, RNF144B, COX10, IVD, NDUFS6, and GCDH) directly, as well as IDH3B and SDHC, which are part of the citric acid cycle [40], and CCBL1, which is involved in glutamine metabolism [41]. </plain></SENT>
<SENT sid="546" pm="."><plain>HSD17B10 regulates biological potency of steroid hormones but is also involved in mitochondrial β-oxidation of fatty acids [42]. </plain></SENT>
<SENT sid="547" pm="."><plain>PRKAG1, which plays a role in fatty acid synthesis, was also decreased geriatric dogs fed PPB. </plain></SENT>
<SENT sid="548" pm="."><plain>The efficiency of carbohydrate metabolism may be impaired with age due to decreased EDEM2 expression. </plain></SENT>
<SENT sid="549" pm="."><plain>EDEM2 recognizes misfolded endoplasmic reticulum glycoproteins and targets them for destruction [43], [44], however, a direct effect of age on this gene has not been described to date. </plain></SENT>
<SENT sid="550" pm="."><plain>In general, our gene expression data suggest reduced metabolic activity with age, which is in agreement with previously reported data in humans [7], [8]. </plain></SENT>
<SENT sid="551" pm="."><plain>Further studies using calorimetric devices are required to confirm our gene expression data. </plain></SENT>
</text></p><p><text><SENT sid="552" pm="."><plain>It is interesting to note that several genes related to cellular organization and development were up-regulated in geriatric dogs, almost exclusively in those fed PPB. </plain></SENT>
<SENT sid="553" pm="."><plain>Whereas genes related to cell cycle and proliferation and differentiation suggest a decrease in cell division, these organization and development genes were significantly changed in the opposite direction. </plain></SENT>
<SENT sid="554" pm="."><plain>This response could be due to age-related muscle atrophy, where fibrous tissue replaces muscle tissue [45]. </plain></SENT>
<SENT sid="555" pm="."><plain>Moreover, the decreased expression of melusin (ITGB1BP2), which suppresses hypertrophy [46], may indicate an attempt to fill voids left by dead muscle cells. </plain></SENT>
<SENT sid="556" pm="."><plain>Cell hypertrophy would require an increase in size of the structural proteins (e.g., PDE4DIP, DMN, and ABLIM1) and functional proteins (e.g., MYBPC1, NEB, and TTN), which is in agreement with the observed up-regulation of these genes. </plain></SENT>
<SENT sid="557" pm="."><plain>Additionally, an increase in expression of genes related to cytokinesis was also noted (SEPT11 and MYH10), further underscoring the possibility of cellular hypertrophy. </plain></SENT>
</text></p><p><text><SENT sid="558" pm="."><plain>As individuals age, oxidative damage to tissues tends to increase. </plain></SENT>
<SENT sid="559" pm="."><plain>This is especially the case in highly oxidative tissues such as skeletal muscle [4]. </plain></SENT>
<SENT sid="560" pm="."><plain>Oxidative damage, in turn, leads to the induction of genes that counteract the effects of oxidative stress [9]. </plain></SENT>
<SENT sid="561" pm="."><plain>Interestingly, a gene such as PRDX5, which has antioxidant activity had lower expression in aged dogs, which is in agreement with observations in aged mouse hearts [47]. </plain></SENT>
<SENT sid="562" pm="."><plain>ADA was also down-regulated in geriatric dogs, but is typically not highly expressed in skeletal muscle [48]. </plain></SENT>
<SENT sid="563" pm="."><plain>Although ADA is linked to development of the immune system in humans (deficiency causes severe combined immunodeficiency disorder), specifically in the spleen [48], its function in muscle may be limited to purine metabolism. </plain></SENT>
<SENT sid="564" pm="."><plain>The up-regulation of DSE (formerly known as SART2) in skeletal muscle of geriatric dogs may be related the oxidative damage in older tissues, as DSE is a tumor antigen that is recognized by cytotoxic T cells and is typically highly expressed in tumor cells [49]. </plain></SENT>
</text></p><p><text><SENT sid="565" pm="."><plain>Although no consistent trends were observed, age also affected some genes associated with cell signaling or transport. </plain></SENT>
<SENT sid="566" pm="."><plain>AKAP13, recently identified as a modulator of Toll-like receptor 2, was up-regulated in geriatric dogs. </plain></SENT>
<SENT sid="567" pm="."><plain>It has the ability to activate NF-κB and therefore activate the innate immune response [50], which could potentially be a response to age-related increased oxidative damage in muscle cells. </plain></SENT>
<SENT sid="568" pm="."><plain>Synaptic vesicle function appears to be impaired in geriatric dogs given the down-regulation of RAB3A. </plain></SENT>
<SENT sid="569" pm="."><plain>This gene plays a role in neurotransmitter release [51], [52] which may be negatively affected as synaptic vesicle density decreases with age [53]. </plain></SENT>
<SENT sid="570" pm="."><plain>SEC61A2 is an essential part of the endoplasmic reticulum protein translocation complex [54] and its transcription may be regulated in a p53-dependent manner [55]. </plain></SENT>
<SENT sid="571" pm="."><plain>This latter mechanism may also reciprocally affect SLC6A6 expression, as p53 represses SLC6A6 expression [56]. </plain></SENT>
<SENT sid="572" pm="."><plain>SLC6A6 is ubiquitously expressed in human tissues [57] and is a sodium dependent taurine transporter that has been implicated in mental retardation in humans [56], but its function in dogs, and specifically skeletal muscle, is not known. </plain></SENT>
<SENT sid="573" pm="."><plain>The expression of SLC25A33 is fairly ubiquitous in humans, with the highest expression in testis, skeletal muscle [58], and central nervous system [59] but data in the dog are unavailable. </plain></SENT>
<SENT sid="574" pm="."><plain>As with many members of the large SLC family of carriers, the substrate of SLC25A33 is currently unknown. </plain></SENT>
</text></p><p><text><SENT sid="575" pm="."><plain>Taken together, the age-related changes in gene expression in dogs fed either diet suggest a decreased level of cell development and proliferation, transcription – translation activity, and metabolism. </plain></SENT>
<SENT sid="576" pm="."><plain>Genes up-regulated with age (mostly in dogs fed PPB) suggest responses to a “troubled” system, initiating hypertrophy of remaining cells in order to avoid muscle tissue from being replaced with non-muscle tissue. </plain></SENT>
<SENT sid="577" pm="."><plain>It should be noted that a considerably larger number of genes than are listed in Tables 1, 2, and 3 were affected by age. </plain></SENT>
<SENT sid="578" pm="."><plain>A complete list of genes affected by age is reported in Table S1. </plain></SENT>
</text></p><p><text><SENT sid="579" pm="."><plain>Only four genes were differentially expressed in skeletal muscle of young adult dogs as affected by diet (MCCC2, MAOB, SNF8, and UNQ1887; Table 4). </plain></SENT>
<SENT sid="580" pm="."><plain>MCCC2 is a carboxylase involved in leucine catabolism [60], while MAOB catalyzes the oxidative deamination of biogenic amines including dopamine, serine, adrenalin and nor-adrenalin [61], [62]. </plain></SENT>
<SENT sid="581" pm="."><plain>SNF8 (in yeast) has a human homologue known as EAP30 subunit of the ELL complex (a transcription factor) that increases gene expression [63]. </plain></SENT>
<SENT sid="582" pm="."><plain>The aspartyl protease UNQ1887 (also known as SPPL3) is located in the endoplasmic reticulum and is thought to be involved in the clearance of signal peptides [64]. </plain></SENT>
</text></p><p><text><SENT sid="583" pm="."><plain>In geriatric dogs, differential gene expression as affected by diet was more prevalent. </plain></SENT>
<SENT sid="584" pm="."><plain>Because geriatric dogs are in a “steady-state” as compared to growing dogs, relatively small dietary manipulations may result in larger gene expression changes. </plain></SENT>
<SENT sid="585" pm="."><plain>More differentially expressed genes were present in geriatric dogs fed the animal-based diet, but consistent patterns did not exist. </plain></SENT>
<SENT sid="586" pm="."><plain>Because of the reduced caloric density and nutrient digestibility of the PPB diet, dogs fed that treatment had a 55% higher protein intake and consumed 13% more calories compared with dogs fed the APB diet. </plain></SENT>
<SENT sid="587" pm="."><plain>Conversely, dogs fed the APB diet had a 57% higher fat intake [14]. </plain></SENT>
<SENT sid="588" pm="."><plain>These differences may have contributed to our results. </plain></SENT>
</text></p><p><text><SENT sid="589" pm="."><plain>Genes associated with muscle contraction were down-regulated in geriatric dogs fed the APB diet. </plain></SENT>
<SENT sid="590" pm="."><plain>Helman et al. [65] reported that dogs fed diets containing animal protein (chicken) were better able to control calpastatin-related protein degradation than those fed diets containing corn gluten meal. </plain></SENT>
<SENT sid="591" pm="."><plain>Further research is necessary to determine whether decreased expression of MYBPC1 and TTN in geriatric dogs fed APB as compared to PPB in this experiment are mechanisms by which this occurs. </plain></SENT>
<SENT sid="592" pm="."><plain>Genes associated with signaling mechanisms were also decreased in geriatric dogs fed the APB diet. </plain></SENT>
<SENT sid="593" pm="."><plain>Such genes have been reported to function in tissue regeneration (LIFR) [66], cell growth (JAK1 [67] and GNB2L1 [68]), and axon guidance (FEZ2) [69]. </plain></SENT>
</text></p><p><text><SENT sid="594" pm="."><plain>Taken together, our results suggest that age, more so than diet, affected gene expression in skeletal muscle tissue of dogs in the current experiment. </plain></SENT>
<SENT sid="595" pm="."><plain>Similar results were noted in the brain in a previously published paper from this project [16]. </plain></SENT>
<SENT sid="596" pm="."><plain>Although acute changes in nutrient composition may affect a small number of genes in a transient manner, age has a prolonged effect [5], [9], [38]. </plain></SENT>
<SENT sid="597" pm="."><plain>This experiment has identified age- and diet-induced gene expression changes in canine skeletal muscle, providing a useful foundation for future experiments designed to study muscle aging. </plain></SENT>
<SENT sid="598" pm="."><plain>Applications could include nutraceutical development for the protection from age-related skeletal muscle function and strength decline. </plain></SENT>
<SENT sid="599" pm="."><plain>To more precisely assess the effects of such compounds, long-term studies analyzing skeletal muscle biopsy samples over the life span of the animal may be useful. </plain></SENT>
<SENT sid="600" pm="."><plain>As our knowledge of gene function and gene-gene interaction expands, nutritional supplements designed to influence specific targets may be designed. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="s3"><title><text><SENT sid="601" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="602" pm="."><plain>Animals and diets </plain></SENT>
</text></title><p><text><SENT sid="603" pm="."><plain>The University of Illinois Animal Care and Use committee approved all animal care procedures prior to initiation of this experiment. </plain></SENT>
<SENT sid="604" pm="."><plain>Twelve female beagle dogs were used in this experiment. </plain></SENT>
<SENT sid="605" pm="."><plain>Six dogs were geriatric (average age: 11.1 yr at the start of the experiment; Kennelwood Inc., Champaign, IL) and six dogs were of weanling age (8 wk at the start of the experiment; Marshall Farms USA, Inc., North Rose, NY). </plain></SENT>
<SENT sid="606" pm="."><plain>Dogs were housed in temperature controlled rooms (22.2°C) in individual kennels (1.1 m×0.9 m), with a 12-h light∶12-h dark cycle at the Edward R. </plain></SENT>
<SENT sid="607" pm="."><plain>Madigan Laboratory on the University of Illinois campus. </plain></SENT>
<SENT sid="608" pm="."><plain>At time of tissue collection, the mean age of the geriatric dogs was 12 y, and that of the young adults was 14 mo. </plain></SENT>
</text></p><p><text><SENT sid="609" pm="."><plain>Three dogs of each age group were assigned to one of two dietary treatments. </plain></SENT>
<SENT sid="610" pm="."><plain>Complete ingredient and chemical composition is presented in Table 5. </plain></SENT>
<SENT sid="611" pm="."><plain>Briefly, one diet was formulated with animal-based protein sources (APB) and the second diet was formulated with plant-based protein sources (PPB). </plain></SENT>
<SENT sid="612" pm="."><plain>Both diets were formulated to meet or exceed nutrient requirements for growing dogs according to the Association of American Feed Control Officials [70]. </plain></SENT>
<SENT sid="613" pm="."><plain>The PPB diet was designed to have lower nutrient digestibility compared to the APB diet, and had a lower caloric density. </plain></SENT>
<SENT sid="614" pm="."><plain>Diets were produced in dry, kibble form by Wenger Manufacturing Company (Sabetha, KS) and fed for 12 mo. </plain></SENT>
<SENT sid="615" pm="."><plain>Young adult dogs were fed ad libitum to support growth and the geriatric dogs were fed to maintain initial BW throughout the experiment. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0004481-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004481.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="616" pm="."><plain>Ingredient and chemical composition of diets fed to young adult and geriatric dogs for 12 months. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0004481-t005-5" xlink:href="pone.0004481.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>Ingredient </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>APB1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>PPB2 </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1"><text><SENT sid="620" pm="."><plain>%, as-is </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>Corn </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>45.00 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>Brewers rice </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>44.23 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>Poultry byproduct meal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>32.91 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>Soybean meal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>19.96 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>Poultry fat </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>14.99 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>3.97 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>Wheat middlings </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>13.20 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>Meat and bone meal </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>- </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>10.00 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>Beet pulp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>4.00 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>4.00 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>Dehydrated egg </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>2.20 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>2.20 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>Sodium chloride </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>0.65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>0.65 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>Potassium chloride </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>0.65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>0.65 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>Choline chloride </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>0.13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>0.13 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>Vitamin premix3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>0.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>0.12 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>Mineral premix3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>0.12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>0.12 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>Analyzed composition </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>Dry matter, % </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>93.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>94.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1"><text><SENT sid="667" pm="."><plain>% DM-basis </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>Organic matter </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>92.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>92.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>Ash </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>7.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>7.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>Crude protein </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>28.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>25.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>Acid hydrolyzed fat </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>22.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>11.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>Total dietary fiber </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>4.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>15.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>Gross energy, kJ/g </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>22.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>19.8 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><label>1</label><p><text><SENT sid="686" pm="."><plain>Provided per kg of APB diet: choline, 2654 mg; retinyl acetate, 15.2 KIU; cholecalciferol, 0.9 KIU; , 62.5 IU; menadione sodium bisulfite complex (source of vitamin K), 0.6 mg; thiamin, 13.1 mg; riboflavin, 14.0 mg; pantothenic acid, 25.3 mg; niacin, 70.0 mg; pyridoxine, 13.56 mg; biotin, 0.11 mg; folic acid, 949 µg; vitamin B-12, 129 µg; manganese (as MnSO4), 19.6 mg; iron (as FeSO4), 253.9 mg; copper (as CuSO4), 17.8 mg; cobalt (as CoSO4), 2.4 mg; zinc (as ZnSO4), 166.9 mg; iodine (as KI), 6.3 mg; and selenium (as Na2SeO3), 0.32 mg. </plain></SENT>
</text></p></fn><fn id="nt106"><label>2</label><p><text><SENT sid="687" pm="."><plain>Provided per kg of PPB diet: choline, 2457 mg; retinyl acetate, 16.3 KIU; cholecalciferol, 0.9 KIU; α-tocopherol, 74.1 IU; menadione sodium bisulfite complex (source of vitamin K), 1.2 mg; thiamin, 14.4 mg; riboflavin, 11.5 mg; pantothenic acid, 23.9 mg; niacin, 79.3 mg; pyridoxine, 15.8 mg; biotin, 0.24 mg; folic acid, 1024 µg; vitamin B-12, 33.3 µg; manganese (as MnSO4), 24.0 mg; iron (as FeSO4), 214.6 mg; copper (as CuSO4), 23.1 mg; cobalt (as CoSO4), 2.4 mg; zinc (as ZnSO4), 144.3 mg; iodine (as KI), 24.0 mg; selenium (as Na2SeO3), 0.27 mg. </plain></SENT>
</text></p></fn><fn id="nt107"><label>3</label><p><text><SENT sid="688" pm="."><plain>Trouw Nutrition USA, LLC, Highland, IL. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s3b"><title><text><SENT sid="689" pm="."><plain>Tissue collection and RNA extraction </plain></SENT>
</text></title><p><text><SENT sid="690" pm="."><plain>After 12 mo on experiment, dogs were euthanized after a 12-h fast by administering a lethal dose of sodium pentobarbital (130 mg/kg BW; Euthasol, Virbac Corp., Forth Worth, TX). </plain></SENT>
<SENT sid="691" pm="."><plain>After death was confirmed by lack of a pulse, corneal reflex, and heartbeat, muscle tissue samples were immediately taken from the biceps femoris and flash-frozen in liquid nitrogen. </plain></SENT>
<SENT sid="692" pm="."><plain>Tissue samples were stored at −80°C until further processing. </plain></SENT>
</text></p><p><text><SENT sid="693" pm="."><plain>Total cellular RNA was extracted from tissue samples using the Trizol method according to manufacturer's instructions (Invitrogen, Carlsbad, CA). </plain></SENT>
<SENT sid="694" pm="."><plain>RNA was quantified on an ND-1000 spectrometer (Nanodrop Technologies, Wilmington, DE) and RNA quality verified on 1.2% agarose gels. </plain></SENT>
<SENT sid="695" pm="."><plain>All individual tissue RNA samples were analyzed individually to assess inter-animal variation. </plain></SENT>
</text></p></sec><sec id="s3c"><title><text><SENT sid="696" pm="."><plain>Microarray procedure </plain></SENT>
</text></title><p><text><SENT sid="697" pm="."><plain>All RNA samples were analyzed by hybridization to the Affymetrix GeneChip® Canine Genome Arrays (Affymetrix, Santa Clara, CA). </plain></SENT>
<SENT sid="698" pm="."><plain>Hybridization reactions were performed using Affymetrix GeneChip Expression 3′-Amplification Reagents (One-Cycle Target Labeling and Control Reagents package) according to manufacturer instructions and as described by Swanson et al. [16]. </plain></SENT>
</text></p><p><text><SENT sid="699" pm="."><plain>After hybridization, the microarray chips were washed and stained using a streptavidin-conjugated phycoerythrin dye (Invitrogen) enhanced with biotinylated goat anti-streptavidin antibody (Vector Laboratories, Burlingame, CA) using an Affymetrix GeneChip Fluidics Station 450 and Genechip Operating Software. </plain></SENT>
<SENT sid="700" pm="."><plain>Images were scanned using an Affymetrix GeneChip scanner 3000. </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="701" pm="."><plain>Microarray data analysis </plain></SENT>
</text></title><p><text><SENT sid="702" pm="."><plain>We used Affymetrix's Canine Genome array (23,836 total probes) to interrogate approximately 21,700 transcripts for C. familiaris obtained from GenBank (August 2003), dbEST (October 2003), and cDNA libraries from 11 tissues, including skeletal muscle, licensed from LION bioscience AG. </plain></SENT>
<SENT sid="703" pm="."><plain>Quality control measures included Affymetrix's recommended measures, as well as assessments using the affy [71], affyPLM [72], and made4 [73] packages from the Bioconductor project [74]. </plain></SENT>
<SENT sid="704" pm="."><plain>All of the arrays passed quality control. </plain></SENT>
</text></p><p><text><SENT sid="705" pm="."><plain>Each probe set contained 11 perfect match (PM) and 11 mismatch (MM) probes. </plain></SENT>
<SENT sid="706" pm="."><plain>The raw PM and MM probe-level data were pre-processed into one number per probe set using the GCRMA algorithm in Bioconductor's affy [71] and GCRMA [75] packages. </plain></SENT>
<SENT sid="707" pm="."><plain>GCRMA does a GC-content-based background correction, performs quantile normalization and then summarizes the PM values into one number using median polish. </plain></SENT>
<SENT sid="708" pm="."><plain>Because the Canine Genome array contains transcripts from many tissues, we used Affymetrix's call detection algorithm [76] to assess which probe sets were reliably detected above background on each array. </plain></SENT>
<SENT sid="709" pm="."><plain>Probe sets were discarded from further analysis if they were not called present on at least one array or marginal on two arrays. </plain></SENT>
<SENT sid="710" pm="."><plain>Of the 23,836 total probe sets, 13,405 passed this filter and were assessed for differential expression due to age and diet (described below). </plain></SENT>
<SENT sid="711" pm="."><plain>Heat maps were generated using the Heatplus [77] package from Bioconductor [74]. </plain></SENT>
<SENT sid="712" pm="."><plain>Meta-Core (GeneGo, Inc., St. Joseph, MI) was used to build gene networks and interpret microarray data. </plain></SENT>
<SENT sid="713" pm="."><plain>Functional attribution was made according to the database SOURCE (<ext-link ext-link-type="uri" xlink:href="http://source.stanford.edu">http://source.stanford.edu</ext-link>) [78]. </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="714" pm="."><plain>qRT-PCR analysis </plain></SENT>
</text></title><p><text><SENT sid="715" pm="."><plain>Quanitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was used to validate a subset of genes expressed differentially based on microarray results. </plain></SENT>
<SENT sid="716" pm="."><plain>Gene-specific primer-probe pairs were designed for each gene using Primer Express 2.0 software (PerkinElmer, Boston, MA). </plain></SENT>
<SENT sid="717" pm="."><plain>cDNA was prepared from tissue RNA samples using the High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). </plain></SENT>
<SENT sid="718" pm="."><plain>cDNA samples then were evaluated using real-time two-step qRT-PCR using an Applied Biosystems Taqman Gene Expression Assay containing a FAM dye-labeled Taqman MGB probe on the Applied Biosystems 7900HT Real-Time PCR System. </plain></SENT>
<SENT sid="719" pm="."><plain>Gene validation was done in triplicate using a control sample to assemble a standard curve. </plain></SENT>
<SENT sid="720" pm="."><plain>Eukaryotic 18S rRNA was amplified as a control in parallel with the gene of interest. </plain></SENT>
<SENT sid="721" pm="."><plain>After amplification, data were normalized to 18S rRNA and expressed as a ratio to the 18S rRNA signal. </plain></SENT>
</text></p></sec><sec id="s3f"><title><text><SENT sid="722" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="723" pm="."><plain>Differential expression of the microarray data was evaluated using the limma package [79]. </plain></SENT>
<SENT sid="724" pm="."><plain>A linear model for the four age×diet groups was fit for each probe set. </plain></SENT>
<SENT sid="725" pm="."><plain>Differences between groups were then extracted from the model as contrasts. </plain></SENT>
<SENT sid="726" pm="."><plain>An empirical Bayes “shrinkage” method was employed on the standard errors to improve power for small sample sizes [79]. </plain></SENT>
<SENT sid="727" pm="."><plain>Last, multiple test correction of P-values was done using the false discovery rate (FDR) method [80]. </plain></SENT>
<SENT sid="728" pm="."><plain>qRT-PCR data were analyzed using the General Linear Models procedure of SAS (SAS Institute., Cary, NC). </plain></SENT>
<SENT sid="729" pm="."><plain>Differences were considered significant when P&lt;0.05. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s4"><title><text><SENT sid="730" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0004481.s001"><label>Table S1</label><caption><p><text><SENT sid="731" pm="."><plain>Complete list of skeletal muscle gene expression in old vs. young adult dogs fed diets formulated with mainly animal-based protein (APB) sources or mainly plant-based protein (PPB) sources (annotated genes only). </plain></SENT>
</text></p><p><text><SENT sid="732" pm="."><plain>(0.28 MB DOC) </plain></SENT>
</text></p></caption><media xlink:href="pone.0004481.s001.doc"><caption><p><text><SENT sid="733" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="734" pm="."><plain>The authors wish to thank Carole Wilson and Jenny Drnevich for their assistance with microarray and statistical analyses. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><fn fn-type="COI-statement"><p><text><SENT sid="735" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><SecTag type="ACK_FUND"><fn fn-type="financial-disclosure"><p><text4fund><text><SENT sid="736" pm="."><plain>Funding: This work was funded in part by the National Center for Supercomputing Applications and the University of Illinois, under auspices of the NCSA/UIUC Faculty Fellows Program, and in part by Pyxis Genomics, Inc., Chicago, IL. </plain></SENT>
<SENT sid="737" pm="."><plain>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. </plain></SENT>
</text></text4fund></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0004481-Levy1"><text><SENT sid="738" pm="."><plain>1 LevyR 1997 Aging-associated cognitive decline. Int Psychogeriatr 6 63 68  </plain></SENT>
</text></ref><ref id="pone.0004481-Petersen1"><text><SENT sid="739" pm="."><plain>2 PetersenRCSmithGEWaringSCIvnikRJKokmenE 1997 Aging, memory, and mild cognitive impairment. Int Psychogeriatr 9 65 69  </plain></SENT>
</text></ref><ref id="pone.0004481-Frontera1"><text><SENT sid="740" pm="."><plain>3 FronteraWRHughesVALutzKJEvansWJ 1991 A cross-sectional study of muscle strength and mass in 45- to78-yr-old men and women. J Appl Physiol 71 644 650 1938738 </plain></SENT>
</text></ref><ref id="pone.0004481-Mecocci1"><text><SENT sid="741" pm="."><plain>4 MecocciPFanoGFulleSMacGarveyUShinobuL 1999 Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radical Biol Med 26 303 308 9895220 </plain></SENT>
</text></ref><ref id="pone.0004481-Barazzoni1"><text><SENT sid="742" pm="."><plain>5 BarazzoniRKShortRNairKS 1999 Effects if aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 275 3343 3347  </plain></SENT>
</text></ref><ref id="pone.0004481-Hagen1"><text><SENT sid="743" pm="."><plain>6 HagenJLKrauseDJBakerDJFuMHTarnopolskyMA 2004 Skeletal muscle aging in F344BN F1-hybrid rats: I Mitochondrial dysfunction contributes to the age-associated reduction in VO2max. J Gerontol 59A 1099 1110  </plain></SENT>
</text></ref><ref id="pone.0004481-Welle1"><text><SENT sid="744" pm="."><plain>7 WelleSBrooksAIDelehantyJMNeedlerNThorntonCA 2003 Gene expression profile of aging human muscle. Physiol Genomics 14 149 159 12783983 </plain></SENT>
</text></ref><ref id="pone.0004481-Zahn1"><text><SENT sid="745" pm="."><plain>8 ZahnJMSonuRVogelHCraneEMazan-MamczarzK 2006 Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet 2 1058 1069  </plain></SENT>
</text></ref><ref id="pone.0004481-Lee1"><text><SENT sid="746" pm="."><plain>9 LeeCKKloppRGWeindruchRProllaTA 1999 Gene expression profile of aging and its retardation by caloric restriction. Science 285 1390 1393 10464095 </plain></SENT>
</text></ref><ref id="pone.0004481-LopezLluch1"><text><SENT sid="747" pm="."><plain>10 Lopez-LluchGHuntNJonesBZhuMJamiesonH 2006 Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci USA 103 1768 1773 16446459 </plain></SENT>
</text></ref><ref id="pone.0004481-Morifuji1"><text><SENT sid="748" pm="."><plain>11 MorifujiMSSakaiKSanbongiCSugiuraK 2005 Dietary whey protein downregulates fatty acid synthesis in the liver, but upregulates it in skeletal muscle of exercise-trained rats. Nutrition 21 1052 1058 16157243 </plain></SENT>
</text></ref><ref id="pone.0004481-Salvadori1"><text><SENT sid="749" pm="."><plain>12 SalvadoriCPetersIRDayMJEngvallESheltonGD 2005 Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy. Muscle and Nerve 31 192 198 15736299 </plain></SENT>
</text></ref><ref id="pone.0004481-Wakshlag1"><text><SENT sid="750" pm="."><plain>13 WakshlagJJBarrSCOrdwayGAKallfelzFAFlahertyCE 2003 Effect of dietary protein on lean body wasting in dogs: Correlation between loss of lean mass and markers of proteasome-dependent proteolysis. J Anim Physiol Anim Nutr 87 408 420  </plain></SENT>
</text></ref><ref id="pone.0004481-Swanson1"><text><SENT sid="751" pm="."><plain>14 SwansonKSKuzmukKNSchookLBFaheyGCJr 2004 Diet affects nutrient digestibility, hematology, and serum chemistry of senior and weanling dogs. J Anim Sci 82 1713 1724 15216999 </plain></SENT>
</text></ref><ref id="pone.0004481-Kuzmuk1"><text><SENT sid="752" pm="."><plain>15 KuzmukKNSwansonKSTappendenKASchookLBFaheyGCJr 2005 Diet and age affect intestinal morphology and large bowel fermentative end-product concentrations in senior and young adult dogs. J Nutr 135 1940 1945 16046720 </plain></SENT>
</text></ref><ref id="pone.0004481-Swanson2"><text><SENT sid="753" pm="."><plain>16 SwansonKSVesterBMApanaviciusCJKirbyNASchookLB 2007 Implications of age and diet on canine cerebral cortex transcription. Neurobiol Aging doi: 101016/jneubiolaging200710017  </plain></SENT>
</text></ref><ref id="pone.0004481-Mannello1"><text><SENT sid="754" pm="."><plain>17 MannelloFGazzanelliG 2001 Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications. Apoptosis 6 479 482 11595838 </plain></SENT>
</text></ref><ref id="pone.0004481-Verhagen1"><text><SENT sid="755" pm="."><plain>18 VerhagenAMEkertPGPakuschMSilkeJConnollyLM 2000 Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 43 53 10929712 </plain></SENT>
</text></ref><ref id="pone.0004481-Lebrin1"><text><SENT sid="756" pm="."><plain>19 LebrinFGoumansM-JJonkerLCarvalhoRLCValdimarsdottirG 2004 Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 23 4018 4028 15385967 </plain></SENT>
</text></ref><ref id="pone.0004481-Beggs1"><text><SENT sid="757" pm="."><plain>20 BeggsMLNagarajanRTaylor-JonesJMNolenGMacNicolM 2004 Alterations in the TGF-β signaling pathway in myogenic progenitors with age. Aging Cell 3 353 361 15569352 </plain></SENT>
</text></ref><ref id="pone.0004481-Williams1"><text><SENT sid="758" pm="."><plain>21 WilliamsRTSeniorPVVan StekelenburgLLaytonJESmithPJ 2002 Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth suppressor activity, contains an extracellular SAM domain modified by N-linked glycosylation. Biochim Biophys Acta 1596 131 137 11983428 </plain></SENT>
</text></ref><ref id="pone.0004481-Brandman1"><text><SENT sid="759" pm="."><plain>22 BrandmanOLiouJParkWSMeyerT 2007 STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 131 1327 1339 18160041 </plain></SENT>
</text></ref><ref id="pone.0004481-Liou1"><text><SENT sid="760" pm="."><plain>23 LiouJLyang KimMDo HeoWJonesJTMyersJW STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Current Biol 15 1235 1241  </plain></SENT>
</text></ref><ref id="pone.0004481-Goll1"><text><SENT sid="761" pm="."><plain>24 GollDEThompsonVFLiHWeiWCongJ 2003 The calpain system. Physiol Rev 83 731 801 12843408 </plain></SENT>
</text></ref><ref id="pone.0004481-Demarchi1"><text><SENT sid="762" pm="."><plain>25 DemarchiFSchneiderC 2007 The calpain system as a modulator of stress/damage response. Cell Cycle 6 136 138 17264674 </plain></SENT>
</text></ref><ref id="pone.0004481-Mirmohammadsadegh1"><text><SENT sid="763" pm="."><plain>26 MirmohammadsadeghATartlerUMichelGBaerAWalzM 2003 HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol 120 1045 1051 12787133 </plain></SENT>
</text></ref><ref id="pone.0004481-Chao1"><text><SENT sid="764" pm="."><plain>27 ChaoJRParganasEBoydKHongCYOpfermanJT 2008 Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 452 98 102 18288109 </plain></SENT>
</text></ref><ref id="pone.0004481-Scortegagna1"><text><SENT sid="765" pm="."><plain>28 ScortegagnaMKingDOktayYGaurAThurmondF 2003 Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice. Nature Genetics 35 331 340 14608355 </plain></SENT>
</text></ref><ref id="pone.0004481-Takeda1"><text><SENT sid="766" pm="."><plain>29 TakedaNMaemuraKImanYHaradaTKawanamiD 2004 Endothelial PAS domain protein 1 gene promotes angiongenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt1. Circ Res 95 146 153 15192019 </plain></SENT>
</text></ref><ref id="pone.0004481-Ohinata1"><text><SENT sid="767" pm="."><plain>30 OhinataYSutouSMitsuiY 2003 A novel testis-specific RAG2-like protein, Peas: Its expression in pachytene spermatocyte cyroplasm and meiotic chromatin. FEBS Letters 537 1 5 12606021 </plain></SENT>
</text></ref><ref id="pone.0004481-Li1"><text><SENT sid="768" pm="."><plain>31 LiYPursellZFLinnS 2000 Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase ε. J Biol Chem 275 23247 23252 10801849 </plain></SENT>
</text></ref><ref id="pone.0004481-Fuss1"><text><SENT sid="769" pm="."><plain>32 FussJLinnS 2002 Human DNA polymerase ε colocalizes with proliferating cell nuclear antigen and DNA replication late, but not early, in S phase. J Biol Chem 277 8658 8666 11741962 </plain></SENT>
</text></ref><ref id="pone.0004481-DelRio1"><text><SENT sid="770" pm="."><plain>33 Del RioMMolinaFBascoul-MolleviCCopoisVBibeauF 2007 Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of Leucovorin, Fluorouracil, and Irinotecan. J Clin Oncol 25 773 780 17327601 </plain></SENT>
</text></ref><ref id="pone.0004481-VelazquezFernandez1"><text><SENT sid="771" pm="."><plain>34 Velazquez-FernandezDLaurellCGeliJHoogAOdebergJ 2005 Expression profiling of adrenocortical neoplasms suggest a molecular signature of malignancy. Surgery 138 1087 1094 16360395 </plain></SENT>
</text></ref><ref id="pone.0004481-Nicholls1"><text><SENT sid="772" pm="."><plain>35 NichollsRDKnepperJL 2001 Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2 153 175 11701647 </plain></SENT>
</text></ref><ref id="pone.0004481-Barr1"><text><SENT sid="773" pm="."><plain>36 BarrJAJonesJGlenisterPHCattanachBM 1995 Ubiquitous expression and imprinting of SNRPN in the mouse. Mammalian Genome 6 405 407 7647462 </plain></SENT>
</text></ref><ref id="pone.0004481-Slizhikova1"><text><SENT sid="774" pm="."><plain>37 SlizhikovaDKVinogradovaTVSverdlovED 2005 The NOLA2 and RPS3A genes as highly informative markers of human squamous cell carcinoma of lung. Russian J Bioorganic Chem 31 178 182  </plain></SENT>
</text></ref><ref id="pone.0004481-Brierley1"><text><SENT sid="775" pm="."><plain>38 BrierleyEJJohnsonMALightowlersRNJamesOFW 1998 Turnbull DM Role of mitochondrial DNA mutation in human aging: Implications for the central nervous system and muscle. Ann Neurol 43 217 223 9485063 </plain></SENT>
</text></ref><ref id="pone.0004481-Cooper1"><text><SENT sid="776" pm="."><plain>39 CooperJMMannVMSchapiraAHV 1992 Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in skeletal muscle: Effect of ageing. J Neurol Sci 113 91 98 1469460 </plain></SENT>
</text></ref><ref id="pone.0004481-Basso1"><text><SENT sid="777" pm="."><plain>40 BassoDMillinoCGrecoERomualdiCFogarP 2004 Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: Searching for a gene expression patterns with a microarray analysis of 5000 skeletal muscle genes. Gut 53 1159 1166 15247186 </plain></SENT>
</text></ref><ref id="pone.0004481-Cooper2"><text><SENT sid="778" pm="."><plain>41 CooperAJL 2004 The role of glutamine transaminase K (GTK) in sulfur and α-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem Int 44 557 577 15016471 </plain></SENT>
</text></ref><ref id="pone.0004481-Mindnich1"><text><SENT sid="779" pm="."><plain>42 MindnichRMollerGAdamskiJ 2004 The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 218 7 20 15130507 </plain></SENT>
</text></ref><ref id="pone.0004481-Mast1"><text><SENT sid="780" pm="."><plain>43 MastSWDiekmanKKaravegKDavisASifersRN 2005 Human EDEM2, a novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. Glycobiology 15 421 436 15537790 </plain></SENT>
</text></ref><ref id="pone.0004481-Olivari1"><text><SENT sid="781" pm="."><plain>44 OlivariSMolinariM 2007 Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins. FEBS Letters 581 3658 3664 17499246 </plain></SENT>
</text></ref><ref id="pone.0004481-Lexell1"><text><SENT sid="782" pm="."><plain>45 LexellJTaylorCCSjostromM 1988 What is the cause of the ageing atrophy? J Neurol Sci 84 275 294 3379447 </plain></SENT>
</text></ref><ref id="pone.0004481-Brancaccio1"><text><SENT sid="783" pm="."><plain>46 BrancaccioMFrattaLNotteAHirschEPouletR 2003 Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic stress overload. Nature Medicine 9 68 75  </plain></SENT>
</text></ref><ref id="pone.0004481-Edwards1"><text><SENT sid="784" pm="."><plain>47 EdwardsMGSarkarDKloppRMorrowJDWeindruchR 2003 Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart. Physiol Genomics 13 119 127 12595580 </plain></SENT>
</text></ref><ref id="pone.0004481-Moriwaki1"><text><SENT sid="785" pm="."><plain>48 MoriwakiYYamamotoTHigashinoK 1999 Enzymes involved in purine metabolism – A review of histochemical localization and functional implications. Histol Histolpathol 14 1321 1340  </plain></SENT>
</text></ref><ref id="pone.0004481-Maccarana1"><text><SENT sid="786" pm="."><plain>49 MaccaranaMOlanderBMalmstromJTiedemannKAebersoldR 2006 Biosynthesis of dermatan sulfate Chondroitin-glucoronate C5-epimerase is identical to SART2. J Biol Chem 281 11560 11568 16505484 </plain></SENT>
</text></ref><ref id="pone.0004481-Shibolet1"><text><SENT sid="787" pm="."><plain>50 ShiboletOGiallourakisCRosenbergIMuellerTXavierRJ 2007 AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling. J Biol Chem 282 35308 35317 17878165 </plain></SENT>
</text></ref><ref id="pone.0004481-Geppert1"><text><SENT sid="788" pm="."><plain>51 GeppertMBolshakovVYSiegelbaumSATakeiKDe CamilliP 1994 The role of Rab3A in neurotransmitter release. Nature 369 493 497 7911226 </plain></SENT>
</text></ref><ref id="pone.0004481-Geppert2"><text><SENT sid="789" pm="."><plain>52 GeppertMGodaYStevensCFSudhofTC 1997 The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature 387 810 814 9194562 </plain></SENT>
</text></ref><ref id="pone.0004481-Naguib1"><text><SENT sid="790" pm="."><plain>53 NaguibMFloodPMcArdleJJBrennerHR 2002 Advances in neurobiology of the neuromuscular junction. Anesthesiology 96 202 231 11753022 </plain></SENT>
</text></ref><ref id="pone.0004481-Knight1"><text><SENT sid="791" pm="."><plain>54 KnightBCHighS 1998 Membrane integration of Sec61α: A core component of the endoplasmic reticulum translocation complex. Biochem J 331 161 167 9512475 </plain></SENT>
</text></ref><ref id="pone.0004481-Zeng1"><text><SENT sid="792" pm="."><plain>55 ZengJYanJWangTMosbrook-DavisDDolanKT 2008 Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteins. Nucleic Acids Res 36 e8 2008 18086703 </plain></SENT>
</text></ref><ref id="pone.0004481-Chen1"><text><SENT sid="793" pm="."><plain>56 ChenNHReithMEAQuickMW 2004 Synaptic uptake and beyond: The sodium- and chloride-dependent neurotransmitter transporter family SLC6. Eur J Physiol 447 519 531  </plain></SENT>
</text></ref><ref id="pone.0004481-Nishimura1"><text><SENT sid="794" pm="."><plain>57 NishimuraMNaitoS 2005 Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20 452 477 16415531 </plain></SENT>
</text></ref><ref id="pone.0004481-Nishimura2"><text><SENT sid="795" pm="."><plain>58 NishimuraMNaitoS 2008 Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 23 22 44 18305372 </plain></SENT>
</text></ref><ref id="pone.0004481-Haitina1"><text><SENT sid="796" pm="."><plain>59 HaitinaTLindblomJRenstromTFrederikssonR 2006 Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics 88 779 790 16949250 </plain></SENT>
</text></ref><ref id="pone.0004481-Baumgartner1"><text><SENT sid="797" pm="."><plain>60 BaumgartnerMRAlamshanuSSuormalaTObieCColeRN 2001 The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. J Clin Invest 107 495 504 11181649 </plain></SENT>
</text></ref><ref id="pone.0004481-Mellick1"><text><SENT sid="798" pm="."><plain>61 MellickGDBuchananDDMcCannSJJamesKMJohnsonAG 1999 Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Movement Disorders 14 219 224 10091612 </plain></SENT>
</text></ref><ref id="pone.0004481-Shih1"><text><SENT sid="799" pm="."><plain>62 ShihJCChenKRiddMJ 1999 Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22 197 217 10202537 </plain></SENT>
</text></ref><ref id="pone.0004481-Schmidt1"><text><SENT sid="800" pm="."><plain>63 SchmidtAEMillerTSchmidtSLShiekhattarRShilatifardA 1999 Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transctiption by RNA polymerase II. J Biol Chem 274 21981 29985 10419521 </plain></SENT>
</text></ref><ref id="pone.0004481-Krawitz1"><text><SENT sid="801" pm="."><plain>64 KrawitzPHaffnerCFluhrerRSteinerHSchmidB 2005 Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3. J Biol Chem 280 39515 39523 15998642 </plain></SENT>
</text></ref><ref id="pone.0004481-Helman1"><text><SENT sid="802" pm="."><plain>65 HelmanEEHuff-LonerganEDavenportGMLonerganSM 2003 Effect of dietary protein on calpastatin in canine skeletal muscle. J Anim Sci 81 2199 2205 12968694 </plain></SENT>
</text></ref><ref id="pone.0004481-Kami1"><text><SENT sid="803" pm="."><plain>66 KamiKMorikawaYKawaiYSenbaE 1999 Leukemia inhibitory factor, gial cell line-derived neurotrophic factor, and their receptor expression following muscle crush injury. Muscle Nerve 22 1576 1586 10514237 </plain></SENT>
</text></ref><ref id="pone.0004481-RicoBautista1"><text><SENT sid="804" pm="."><plain>67 Rico-BautistaEFlores-MoralesAFernandez-PerezL 2006 Suppressor of cytokine signaling (SOCS), a protein with multiple functions. Cytokine and Growth Factor Rev 17 431 439 17070092 </plain></SENT>
</text></ref><ref id="pone.0004481-Chang1"><text><SENT sid="805" pm="."><plain>68 ChangBYConroyKBMachlederEMCartwrightCA 1998 RACK1, a receptor for activated C kinase and a homolog of the β subunit of G proteins, inhibits activity of Src tyrosine kinases and growth of NIH 3T3 cells. Mol Cell Biol 18 3245 3256 9584165 </plain></SENT>
</text></ref><ref id="pone.0004481-Bloom1"><text><SENT sid="806" pm="."><plain>69 BloomLHorvitzHR 1997 The Caenorhavditis elegans gene unc-76 and its human homologs define a new gene family involved in axonal outgrowth and fasciculation. Proc Natl Acad Sci USA 94 3414 341 9096408 </plain></SENT>
</text></ref><ref id="pone.0004481-AAFCO1"><text><SENT sid="807" pm="."><plain>70 AAFCO 2007 Official Publication Oxford, IN Assoc Am Feed Control Offic, Inc 476  </plain></SENT>
</text></ref><ref id="pone.0004481-Gautier1"><text><SENT sid="808" pm="."><plain>71 GautierLCopeLBolstadBMIrizarryRA 2003 Affy – analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20 307 315  </plain></SENT>
</text></ref><ref id="pone.0004481-Bolstad1"><text><SENT sid="809" pm="."><plain>72 BolstadBM 2004 Low level analysis of high-density oligonucleotide array data: Background, normalization and summarization Berkeley, CA PhD dissertation, University of California 137  </plain></SENT>
</text></ref><ref id="pone.0004481-Culhane1"><text><SENT sid="810" pm="."><plain>73 CulhaneACThioulouseJPerriereGHigginsDG 2005 MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 21 2789 2790 15797915 </plain></SENT>
</text></ref><ref id="pone.0004481-Gentleman1"><text><SENT sid="811" pm="."><plain>74 GentlemanRCCareyVJBatesDMBolstadBDettlingsM 2004 Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5 R8 14759258 </plain></SENT>
</text></ref><ref id="pone.0004481-Irizarry1"><text><SENT sid="812" pm="."><plain>75 IrizarryRAHobbsBCollinFBeazer-BarclayYDAntonellisKJ 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 249 264 12925520 </plain></SENT>
</text></ref><ref id="pone.0004481-GeneChip1"><text><SENT sid="813" pm="."><plain>76 GeneChip 2002 Expression analysis data analysis fundamentals manual Santa Clara, CA Affymetrix 42  </plain></SENT>
</text></ref><ref id="pone.0004481-Ploner1"><text><SENT sid="814" pm="."><plain>77 PlonerA 2006 Heatplus: A heat map displaying covariates and coloring clusters. R Package version 240  </plain></SENT>
</text></ref><ref id="pone.0004481-Diehn1"><text><SENT sid="815" pm="."><plain>78 DiehnMSherlockGBinkleyGJinHMateseJC 2003 SOURCE: A unified genomic resource of functional annotations, ontologies, and gene expression dat. Nucleic Acids Res 31 219 223 12519986 </plain></SENT>
</text></ref><ref id="pone.0004481-Smyth1"><text><SENT sid="816" pm="."><plain>79 SmythGK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Applic Genet Mol Biol 3 article 3  </plain></SENT>
</text></ref><ref id="pone.0004481-Benjamini1"><text><SENT sid="817" pm="."><plain>80 BenjaminiYHochbergY 1995 Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B57 289 300  </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
